Advertisement
News
Advertisement

St. Jude Revisits RESPECT Trial, Touts Signs of Benefits of Amplatzer Device

Fri, 02/08/2013 - 3:18pm
Mass Device

St. Jude Medical touts new findings from its failed RESPECT trial, reporting that the Amplatzer PFO closure device demonstrated benefits over drug therapy alone.

St. Jude Medical logo

Medical device giant St. Jude Medical (NYSE:STJ) resurrected data from its failed RESPECT study, touting additional analyses and benefits of its Amplatzer patent foramen ovale closure device.

St. Jude took a hit last year when the RESPECT trial failed to meet its clinical endpoints, but the company wasn't about to stop there.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading